193 related articles for article (PubMed ID: 5583441)
41. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
Denber HC
Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
[No Abstract] [Full Text] [Related]
42. A bufotenin-like substance in the urine of schizophrenics.
FISCHER E; FERNANDEZ LAGRAVERE TA; VAZQUEZ AJ; DI STEFANO AO
J Nerv Ment Dis; 1961 Nov; 133():441-4. PubMed ID: 13893116
[No Abstract] [Full Text] [Related]
43. [Quantitative determination of bufotenin in urine of normals and mental patients].
Spatz H
Prensa Med Argent; 1967 Nov; 54(38):2116-7. PubMed ID: 5613517
[No Abstract] [Full Text] [Related]
44. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
Gallant DM; Bishop M; Guerrero-Figueroa R
Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
[No Abstract] [Full Text] [Related]
45. Trifluperidol and trifluoperazine in acute schizophrenic patients.
Sugerman AA; Williams BH
J New Drugs; 1965; 5(5):318-26. PubMed ID: 5329635
[No Abstract] [Full Text] [Related]
46. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
[No Abstract] [Full Text] [Related]
47. Bufotenin like substances in form of glucuronide in schizophrenic and normal urines.
Fischer E; Spatz H; Fledel T
Psychosomatics; 1971; 12(4):278-80. PubMed ID: 5172934
[No Abstract] [Full Text] [Related]
48. [Morphological aspects of the association of triperidol and thioridazine. (Histological experimental study)].
Pastena L; Ranzato FP
Riv Neurobiol; 1968; 14(4):632-43. PubMed ID: 5738412
[No Abstract] [Full Text] [Related]
49. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
[No Abstract] [Full Text] [Related]
50. [Determination of bufotenin appearing in the urine of schizophrenics. (Preliminary note)].
FISCHER E; FERNANDEZ TA; LISKOWSKI L; VAZQUEZ AJ
Prensa Med Argent; 1960 Dec; 47():3188-9. PubMed ID: 13699820
[No Abstract] [Full Text] [Related]
51. Treatment considerations in the adolescent inpatient; report on ninety-two cases compared with ninety-two adults.
Gralnick A; Rabiner EL; del Castillo G; Zawel D
Dis Nerv Syst; 1969 Dec; 30(12):833-42. PubMed ID: 5369135
[No Abstract] [Full Text] [Related]
52. Further observations on trifluperidol: a butyrophenone derivative.
Gallant DM; Bishop MP; Nesselhof WM; Sprehe DJ
Psychopharmacologia; 1965 Jan; 7(1):37-43. PubMed ID: 5318922
[No Abstract] [Full Text] [Related]
53. [On the position of butyrophenone derivative Triperidol in psychiatric treatment].
Lange E; Scholz V
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875
[No Abstract] [Full Text] [Related]
54. Search for a bufotenin-like substance in the urine of schizophrenics.
Runge TM; Lara FY; Thurman N; Keyes JW; Hoerster SH
J Nerv Ment Dis; 1966 May; 142(5):470-4. PubMed ID: 5915678
[No Abstract] [Full Text] [Related]
55. [Urinary excretion of catecholamines and 3-methoxy-4 hydroxy-mandelic acid in chronic schizophrenic patients undergoing Triperidol treatment].
Masiak M; Zawiślak H
Psychiatr Pol; 1973; 7(6):637-43. PubMed ID: 4773051
[No Abstract] [Full Text] [Related]
56. [Insulinotherapy and schizophrenia].
Luyssaert W; Pierloot R
Acta Neurol Psychiatr Belg; 1969 May; 69(5):315-35. PubMed ID: 4990887
[No Abstract] [Full Text] [Related]
57. [The Wartegg-Sign-Test in schizophrenics].
Knorr W; Rennert H
Fortschr Neurol Psychiatr Grenzgeb; 1966 May; 34(5):276-96. PubMed ID: 5339269
[No Abstract] [Full Text] [Related]
58. Pilot clinical study with trifluperidol (Trisedyl) therapy in psychotic patients.
Dolezalová V; Faltus F; Soucek K
Act Nerv Super (Praha); 1974 Aug; 16(3):171. PubMed ID: 4609154
[No Abstract] [Full Text] [Related]
59. Present controversies in the treatment of schizophrenia.
Kalinowsky LB
Proc Rudolf Virchow Med Soc City N Y; 1972-1973; 29():121-2. PubMed ID: 4155076
[No Abstract] [Full Text] [Related]
60. A guide to the use of psychoactive agents.
Appleton WS
Dis Nerv Syst; 1967 Sep; 28(9):609-13. PubMed ID: 6052928
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
